On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

The U.S. health regulator on Friday approved Innoviva's oral antibiotic to treat gonorrhea, a common sexually transmitted ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

London: GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

EMA committee recommends approval of GSK’s RSV vaccine, Arexvy for all adults 18 years and older: London, UK Saturday, December 13, 2025, 13:00 Hrs [IST] GSK plc announced that ...

London: GSK has announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application for ...

The US Food and Drug Administration (FDA) on Friday announced it has approved two new oral medicines to treat a common ...

US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea: London, UK Saturday, December 13, 2025, 09:00 Hrs [IST] GSK plc announced that ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The ...

The FDA approves two new drugs for gonorrhoea treatment, with Dr. Reddy’s to market one in Thailand and South Africa.

RZV offers substantial clinical and economic benefits but has low uptake among adults aged 50 and older compared to other vaccines. By 2020, only 10.8% of adults aged 50 and older had completed both ...

GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) has shared an update.